France - Pharmaceutical products
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 16 August 2022
- Opportunity publication date
- 15 July 2022
- Category
- 33600000: Ph
- Value of contract
- £100k-1m
- Your guide to exporting
Description
supply of medicines - relaunch of biosimilar infliximab for the benefit of the member establishments of the order group for the supply of pharmaceutical products coordinated by the Centre hospitalier bretagne atlantique
supply of infliximab BIOSIMILAR for the benefit of the member establishments of the order group for the supply of pharmaceutical products (Order Group 56). The public contract is composed of 150 lots; only the lot concerning infliximab BIOSIMILAIRE is concerned by the present consultation. The details, the technical description, the estimated quantity and the maximum quantity appear in the CCTP and in the catalog of requirements
- Opportunity closing date
- 16 August 2022
- Value of contract
- £100k-1m
About the buyer
- Address
- centre hospitalier bretagne atlantique etablissement coordonnateur du Groupement de commandes pour la fourniture de produits du domaine pharmaceutique (groupement de commandes 56), 20 boulevard Général Maurice Guillaudot - bP 70555 Vannes Cedex 56017 France
- Contact
- cellule-juridique.achats@ghba.fr
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.